EGFR and renal cell carcinoma: It was recently demonstrated that EGFR is directly O-GlcNAcylated and that OGT knock-down downregulates EGFR and its downstream PI3K/AKT pathway, and promotes cell cycle arrest and apoptosis in 786-O renal cell carcinoma cells (111).